Association between helicobacter pylori Infection and ulcerative colitis-a case control study from China

International Journal of Medical Sciences

Volumn 10, Issue 11, 2013, Pages 1479-1484

  Jin, Xi ^a   Chen, Yi Peng ^a   Chen, Shao Hua ^a   Xiang, Zun ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Helicobacter pylori; Ulcerative colitis; Urea breath test

Indexed keywords

AMINOSALICYLIC ACID; C REACTIVE PROTEIN; PROTON PUMP INHIBITOR;

ABDOMINAL PAIN; ADULT; AGE; ARTICLE; BODY MASS; CASE CONTROL STUDY; CHINA; COLON; CONTROLLED STUDY; DIABETES MELLITUS; DIARRHEA; DISEASE ASSOCIATION; DISEASE SEVERITY; ERADICATION THERAPY; FEMALE; GASTROINTESTINAL REFLUX; GASTROINTESTINAL SYMPTOM; GENDER; HELICOBACTER INFECTION; HUMAN; HUMAN TISSUE; HYPERTENSION; INFECTION RATE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PROTEIN BLOOD LEVEL; RECTUM HEMORRHAGE; SMOKING HABIT; ULCERATIVE COLITIS;

HELICOBACTER PYLORI; ULCERATIVE COLITIS; UREA BREATH TEST.;

ADULT; CASE-CONTROL STUDIES; CHINA; COLITIS, ULCERATIVE; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED;

EID: 84883308960     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.6934     Document Type: Article

References (48)

1. Danese S, Fiocchi C. Ulcerative colitis. The New England journal of medicine. 2011;365(18):1713-25.
2. Loftus EV, Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology. 2004;126(6):1504-17.
3. Ooi CJ, Fock KM, Makharia GK, et al. The Asia-Pacific consensus on ulcerative colitis. Journal of gastroenterology and hepatology. 2010;25(3):453-68.
4. Sood A, Midha V. Epidemiology of inflammatory bowel disease in Asia. Indian journal of gastroenterology. 2007;26(6):285-9.
5. Lok KH, Hung HG, Ng CH, et al. Epidemiology and clinical characteristics of ulcerative colitis in Chinese population: experience from a single center in Hong Kong. Journal of gastroenterology and hepatology. 2008;23(3):406-10.
6. Jiang L, Xia B, Li J, et al. Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China. Inflammatory bowel diseases. 2006;12(3):212-7.
7. Bloomfield SF, Stanwell-Smith R, Crevel RW, et al. Too clean, or not too clean: the hygiene hypothesis and home hygiene. Clinical and experimental allergy: journal of the British Society for Allergy and Clinical Immunology. 2006;36(4):402-25.
8. Koloski NA, Bret L, Radford-Smith G. Hygiene hypothesis in inflammatory bowel disease: a critical review of the literature. World journal of gastroenterology 2008;14(2):165-73.
9. Linz B, Balloux F, Moodley Y, et al. An African origin for the intimate association between humans and Helicobacter pylori. Nature. 2007;445(7130):915-8.
10. Falush D, Wirth T, Linz B, et al. Traces of human migrations in Helicobacter pylori populations. Science. 2003;299(5612):1582-5.
11. Marshall BJ WJ. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984;1:1311-15.
12. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, et al. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet. 1991;338(8776):1175-6.
13. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. The New England journal of medicine. 1991;325(16):1127-31.
14. van Amsterdam K, van Vliet AH, Kusters JG, et al. Of microbe and man: determinants of Helicobacter pylori-related diseases. FEMS microbiology reviews. 2006;30(1):131-56.
15. Lundgren A, Suri-Payer E, Enarsson K, et al. Helicobacter pylori-specific CD4+ CD25high regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals. Infection and immunity. 2003;71(4):1755-62.
16. Rad R, Brenner L, Bauer S, et al. CD25+/Foxp3+ T cells regulate gastric inflammation and Helicobacter pylori colonization in vivo. Gastroenterology. 2006;131(2):525-37.
17. Danese S, Sans M, Fiocchi C. Inflammatory bowel disease: the role of environmental factors. Autoimmunity reviews. 2004;3(5):394-400.
18. Li Xiu-qing, Pan Li-juan, Tao Zhi-qiang. correlation study between Helicobacter Pylori and ulcerative colitis. Modern Medical Journal. 2010;38(6):647-48.
19. Thia KT, Loftus EV Jr., Sandborn WJ, et al. An update on the epidemiology of inflammatory bowel disease in Asia. The American journal of gastroenterology. 2008;103(12):3167-82.
20. Luther J, Dave M, Higgins PD, et al. Association between Helicobacter pylori infection and inflammatory bowel disease: a meta-analysis and systematic review of the literature. Inflammatory bowel diseases. 2010;16(6):1077-84.
21. Oliveira AG, das Gracas Pimenta Sanna M, Rocha GA, et al. Helicobacter species in the intestinal mucosa of patients with ulcerative colitis. Journal of clinical microbiology. 2004;42(1):384-6.
22. Parlak E, Ulker A, Disibeyaz S, et al. There is no significant increase in the incidence of Helicobacter pylori infection in patients with inflammatory bowel disease in Turkey. Journal of clinical gastroenterology. 2001;33(1):87-8.
23. Xiang Z, Chen YP, Ye YF, et al. Helicobacter pylori and Crohn's disease: A retrospective single-center study from China. World journal of gastroenterology. 2013;19(28):4576-81.
24. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007; 370(9596):1453-7.
25. Rey JF, Lambert R. ESGE recommendations for quality control in gastrointestinal endoscopy: guidelines for image documentation in upper and lower GI endoscopy. Endoscopy. 2001;33(10):901-3.
26. de Lange T, Larsen S, Aabakken L. Inter-observer agreement in the assessment of endoscopic findings in ulcerative colitis. BMC gastroenterology. 2004;4:9.
27. Surveyor I, Goodwin CS, Mullan BP, et al. The 14C-urea breath-test for the detection of gastric Campylobacter pylori infection. The Medical journal of Australia. 1989;151(8):435-9.
28. Chey WD, Wong BC. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. The American journal of gastroenterology. 2007;102(8):1808-25.
29. Megraud F, Lehours P. Helicobacter pylori detection and antimicrobial susceptibility testing. Clinical microbiology reviews. 2007;20(2):280-322.
30. Thompson AI, Lees CW. Genetics of ulcerative colitis. Inflammatory bowel diseases. 2011;17(3):831-48.
31. Parkes M. The genetics universe of Crohn's disease and ulcerative colitis. Digestive diseases (Basel, Switzerland). 2012;30 Suppl 1:78-81.
32. Louis E, Libioulle C, Reenaers C, et al. Genetics of ulcerative colitis: the come-back of interleukin 10. Gut. 2009;58(9):1173-6.
33. Jostins L, Ripke S, Weersma RK, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491(7422):119-24.
34. Sasaki M, Klapproth JM. The role of bacteria in the pathogenesis of ulcerative colitis. Journal of signal transduction. 2012;: 7049-53.
35. Hansen R, Thomson JM, Fox JG, et al. Could Helicobacter organisms cause inflammatory bowel disease? FEMS immunology and medical microbiology. 2011;61(1):1-14.
36. Kullberg MC, Ward JM, Gorelick PL, et al. Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12-and gamma interferon-dependent mechanism. Infection and immunity. 1998;66(11):5157-66.
37. Jergens AE, Wilson-Welder JH, Dorn A, et al. Helicobacter bilis triggers persistent immune reactivity to antigens derived from the commensal bacteria in gnotobiotic C3H/HeN mice. Gut. 2007;56(7):934-40.
38. Ram M, Barzilai O, Shapira Y, et al. Helicobacter pylori serology in autoimmune diseases-fact or fiction? Clinical chemistry and laboratory medicine: CCLM / FESCC. 2013;51(5):1075-82.
39. Bell SJ, Chisholm SA, Owen RJ, et al. Evaluation of Helicobacter species in inflammatory bowel disease. Alimentary pharmacology & therapeutics. 2003;18(5): 481-6.
40. Grehan M, Danon S, Lee A, et al. Absence of mucosa-associated colonic Helicobacters in an Australian urban population. Journal of clinical microbiology. 2004;42(2):874-6.
41. He Jin-de, Ye hui, Zhang Jiao. Serologic presentation of helicobacter pylori infection in patients with inflammatory bowel disease. Journal of Chinese Physician. 2003;5(6):737-38.
42. Halme L, Rautelin H, Leidenius M, et al. Inverse correlation between Helicobacter pylori infection and inflammatory bowel disease. Journal of clinical pathology. 1996;49(1):65-7.
43. Pearce CB, Duncan HD, Timmis L, et al. Assessment of the prevalence of infection with Helicobacter pylori in patients with inflammatory bowel disease. European journal of gastroenterology & hepatology. 2000;12(4):439-43.
44. Sagi L, Baum S, Agmon-Levin N, et al. Autoimmune bullous diseases the spectrum of infectious agent antibodies and review of the literature. Autoimmunity reviews. 2011;10(9):527-35.
45. Banka S, Ryan K, Thomson W, et al. Pernicious anemia-genetic insights. Autoimmunity reviews. 2011;10(8):455-9.
46. Tursi A. Onset of Crohn's disease after Helicobacter pylori eradication. Inflammatory bowel diseases. 2006;12(10):1008-9.
47. Wehkamp J, Fellermann K, Herrlinger KR, et al. Mechanisms of disease: defensins in gastrointestinal diseases. Nature clinical practice Gastroenterology & hepatology. 2005;2(9):406-15.
48. Thomas JE. 13C urea breath test. Gut. 1998;43 Suppl 3:S7-12.